Synthesis and Properties of P1, P2-, P1, P3- and P1, P4-Dinucleoside Di-, Tri- and Tetraphosphate mRNA 5′-Cap Analogues

Abstract

Chemically synthesized dinucleoside P¹, P²-di-, P¹, P³-tri- and P¹, P⁴-tetraphosphates, derivatives of 5′-linked 7-methylguanosine and guanosine were characterized with respect to their structural properties and functional effect on eukaryotic translation inhibition.     

质量—数量性状遗传参数估计的P1,P2,F1,B1,B2联合分析方法

提出利用亲本Ｐ_１和Ｐ_２、杂种Ｆ_１、回交Ｂ_１和Ｂ_１五个世代联合分析包括两个位点主基因控制的质量－数量性状遗传的统计方法,共建立了可供选择的微基因遗传、一对主基因＋微基因混合遗传、二对主基因＋微基因混合遗传三类五种（套）共 ２８个遗传模型,采用 ＡＩＣ信息准则选择最适模型,并通过适合性检验对所选择的遗传模型做进一步的检验．文章最后还讨论了两种变型设计．     

Antiplatelet Activity,P2Y1 and P2Y12 Inhibition,and Metabolism in Plasma of Stereoisomers of Diadenosine 5′,5′″-P1,P4-dithio-P2,P3-chloromethylenetetraphosphate

Background

Diadenosine tetraphosphate (Ap₄A), a constituent of platelet dense granules, and its P¹,P⁴-dithio and/or P²,P³-chloromethylene analogs, inhibit adenosine diphosphate (ADP)-induced platelet aggregation. We recently reported that these compounds antagonize both platelet ADP receptors, P2Y₁ and P2Y₁₂. The most active of those analogs, diadenosine 5′,5″″-P¹,P⁴-dithio-P²,P³-chloromethylenetetraphosphate, (compound 1), exists as a mixture of 4 stereoisomers.

Objective

To separate the stereoisomers of compound 1 and determine their effects on platelet aggregation, platelet P2Y₁ and P2Y₁₂ receptor antagonism, and their metabolism in human plasma.

Methods

We separated the 4 diastereomers of compound 1 by preparative reversed-phase chromatography, and studied their effect on ADP-induced platelet aggregation, P2Y₁-mediated changes in cytosolic Ca²⁺, P2Y₁₂-mediated changes in VASP phosphorylation, and metabolism in human plasma.

Results

The inhibition of ADP-induced human platelet aggregation and human platelet P2Y₁₂ receptor, and stability in human plasma strongly depended on the stereo-configuration of the chiral P¹- and P⁴-phosphorothioate groups, the S_PS_P diastereomer being the most potent inhibitor and completely resistant to degradation in plasma, and the R_PR_P diastereomer being the least potent inhibitor and with the lowest plasma stability. The inhibitory activity of S_PR_P diastereomers depended on the configuration of the pseudo-asymmetric carbon of the P²,P³-chloromethylene group, one of the configurations being significantly more active than the other. Their plasma stability did not differ significantly, being intermediate to that of the S_PS_P and the R_PR_P diastereomers.

Conclusions

The presently-described stereoisomers have utility for structural, mechanistic, and drug development studies of dual antagonists of platelet P2Y₁ and P2Y₁₂ receptors.     

制作水稻的P1程序库,克隆恢复基因

三井东压化学生命科学研究所稻垣明子、该研究所小组负责人藤村达人等使用P_1噬菌体载体编制水稻染色体程序库。农业生物资源研究所染色体研究组已使用酵母人工染色体(YAC)建立了水稻染色体程序库。民间企业独自开发水稻染色体库还是第一次。稻垣等在4月2日～3日召开的日本育种学会和4月1～4日召开的农艺化学会上发表了此项研究成果。     

Formation of P1, P2-dinucleoside 5′-pyrophosphates under potentially prebiological conditions

Summary Organic pyrophosphates such as UppA and NAD are formed when a solution containing a nucleotide, a nucleoside 5-polyphosphate, Mg²⁺ and imidazole are allowed to dry out. We suggest that this synthesis may have occured concurrently with oligonucleotide formation.Abbreviations Im Imidazole - CDI 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride - EDTA ethylenediaminetetraacetic acid - A adenosine - U uridine - p_nA adenosine 5-poly-phosphate containing n phosphate residues - pU uridine 5-phosphate - AppA P₁,P₂-diadenosine 5-pyrophosphate - UppA P₁-(uridine 5)-P₂-(adenosine 5)-pyrophosphate - ImpA adenosine 5-phosphorimidazolide - NMN nicotinamide mononucleotide - NAD nicotinamide-adenine dinucleotide     

Chemical Synthesis of Cap Analogues: P1,P2-Dinucleoside-5′-diphosphates

Abstract

A procedure was developed for the chemical synthesis of P¹,P²-dinucleoside-5′-diphosphates (N₁(5′)pp(5′)N₂) on a nanomolar scale Reaction conditions for activating purine-5′-monophosphates (pA, pG, and pm⁷G) by 1,1′-carbonyldiimidazole were studied and optimized in respect to solvents and amount of activating reagent used. Various dinucleoside-5′-diphosphates were synthesized in 62-98% yield by incubating activated and non-activated purine-5′-monophosphates. Two unexpected by-products were formed by competition reactions: the imidazolidate of the non-activated nucleotide and the corresponding symmetrically substituted dinucleoside-5′-diphosphate. A mechanism is proposed to explain the observed side reactions.     

Discovery of thiadiazole amides as potent, S1P₃-sparing agonists of sphingosine-1-phosphate 1 (S1P₁) receptor

High-throughput screening of GSK compound collection led to the discovery of a novel series of thiadiazole amides as potent and S1P(3)-sparing sphingosine-1-phosphate 1 (S1P(1)) receptor agonists. Synthesis, structure and activity relationship, selectivity, and some developability properties are described.     

P1-(Thymidine 5′-)P1-amino-triphosphate: Synthesis,Hydrolysis and Reaction with Cytidine in Alkali1

Abstract

The title compound 1 is prepared from thymidine 5′-phos-phorodiamidate (2) and inorganic pyrophosphate (3) in anhydrous DMF, at 30–32°C. The products of alkaline hydrolysis of 1, at room temperature, are: thymidine 5′-phosphoramidate (4), thymidine 3′-phosphoramidate (8) and thymidine (9) as well as 3 and inorganic trimetaphosphate (10). In 1 N NH₄OH, 1 reacts with cytidine (15) to form cytidylyl-/2^T(3′)-5′/-thymidine (16) and a mixture of cytidine 2′,3′-cyclic phosphate (17) and 9.     

大肠癌P21,P53蛋白表达和k—ras基因,P53基因突变研究

用免疫组化技术和ＰＣＲ－ＳＳＣＰ技术对高、中、低分化大肠腺癌、癌旁粘膜、正常粘膜及大肠腺癌型息肉的Ｐ２１、Ｐ５３蛋白表达和ｋ－ｒａｓ基因、Ｐ５３基因突变进行检测。结果,大肠腺癌Ｐ２１、Ｐ５３蛋白表达比大肠腺瘤增多,但增加不显著（Ｐ〉０．０５）,二组均比癌旁粘膜和正常粘膜Ｐ２１、Ｐ５３蛋白表达阳性率高（Ｐ〈０．０１）,大肠腺癌ｋ－ｒａｓ基因和Ｐ５３基因突变率比大肠腺瘤、癌旁粘膜和正常粘膜组显著增加     

Blocking S1P interaction with S1P₁ receptor by a novel competitive S1P₁-selective antagonist inhibits angiogenesis

Sphingosine 1-phosphate receptor type 1 (S1P(1)) was shown to be essential for vascular maturation during embryonic development and it has been demonstrated that substantial crosstalk exists between S1P(1) and other pro-angiogenic growth factors, such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor. We developed a novel S1P(1)-selective antagonist, TASP0277308, which is structurally unrelated to S1P as well as previously described S1P(1) antagonists. TASP0277308 inhibited S1P- as well as VEGF-induced cellular responses, including migration and proliferation of human umbilical vein endothelial cells. Furthermore, TASP0277308 effectively blocked a VEGF-induced tube formation in vitro and significantly suppressed tumor cell-induced angiogenesis in vivo. These findings revealed that S1P(1) is a critical component of VEGF-related angiogenic responses and also provide evidence for the efficacy of TASP0277308 for anti-cancer therapies.     

P57,P53,bcl-2,ki-67联合应用在葡萄胎诊断中的意义

目的:研究p57,P53,bcl-2,ki-67蛋白表达在完全性葡萄胎(CM)、部分性葡萄胎(PM)及水肿流产胎(HA)的诊断及鉴别诊断意义.方法:对21例完全性葡萄胎,28例部分性葡萄胎,18例水肿流产胎的标本进行4种抗体免疫组化分析,同时选取10例正常胎盘组织作为对照.结果:在CM中,p57表达不明显,而P53,bcl-2,Ki-67表达增强;在PM,HA及对照组中p57呈现高表达,P53,bcl-2,Ki-67则表达较弱.这四种抗体的表达在完全性葡萄胎与部分性葡萄胎、水肿流产胎及对照组之间的差异具有显著性(P＜0.01),而部分性葡萄胎与水肿流产胎、水肿流产胎与对照组之间差异不显著(P＞0.05).结论:p57和Ki-67表达对CM,PM和HA的鉴别诊断有重要作用,而P53,bcl-2表达对判断预后及预测恶变风险有意义.     

Design,synthesis, X-ray studies,and biological evaluation of novel macrocyclic HIV-1 protease inhibitors involving the P1′-P2′ ligands

Design, synthesis, and evaluation of a new class of HIV-1 protease inhibitors containing diverse flexible macrocyclic P1′-P2′ tethers are reported. Inhibitor 5a with a pyrrolidinone-derived macrocycle exhibited favorable enzyme inhibitory and antiviral activity (K_i = 13.2 nM, IC₅₀ = 22 nM). Further incorporation of heteroatoms in the macrocyclic skeleton provided macrocyclic inhibitors 5m and 5o. These compounds showed excellent HIV-1 protease inhibitory (K_i = 62 pM and 14 pM, respectively) and antiviral activity (IC₅₀ = 5.3 nM and 2.0 nM, respectively). Inhibitor 5o also remained highly potent against a DRV-resistant HIV-1 variant.     

Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P₃-sparing S1P₁ agonists

We have previously disclosed 1,2,4-oxadiazole derivative 3 as a potent S1P(3)-sparing S1P(1) agonist. Although compound 3 exhibits potent and manageable immunosuppressive efficacy in various in vivo models, recent studies have revealed that its 1,2,4-oxadiazole ring is subjected to enterobacterial decomposition. As provisions for unpredictable issues, a series of alternative compounds were synthesized on the basis of compound 3. Extensive SAR studies led to the finding of 1,3-thiazole 24c with the EC(50) value of 3.4 nM for human S1P(1), and over 5800-fold selectivity against S1P(3). In rat on host versus graft reaction (HvGR), the ID(50) value of 24c was determined at 0.07 mg/kg. The pharmacokinetics in rat and monkey is also reported. Compared to compound 3, 24c showed excellent stability against enterobacteria.     

Structure-based design and synthesis of novel P2/P3 modified,non-peptidic β-secretase (BACE-1) inhibitors

Starting from peptidomimetic BACE-1 inhibitors, the P2 amino acid including the P2/P3 peptide bond was replaced by a rigid 3-aminomethyl cyclohexane carboxylic acid. Co-crystallization revealed an unexpected binding mode with the P3/P4 amide bond placed into the S3 pocket resulting in a new hydrogen bond interaction pattern. Further optimization based on this structure resulted in highly potent BACE-1 inhibitors with selectivity over BACE-2 and cathepsin D.     

Synthesis of hybrid bisnucleoside 5′, 5‴ — P1, P4 — tetraphosphates by aminoacyl — tRNA synthetases

Aminoacyl tRNA synthetases, by means of a back reaction, are able to synthesize certain 5, 5 - P¹, P⁴ — bisnucleoside tetraphosphates of biological importance, such as ANA. Here it is shown that HisRS and TrpRS (Bacillus stearothermophilus) and AlaRS (E. coli) also synthesize the hybrid compounds Ap₄G, Ap₄C, and Ap₄U. GInRS (E. coli) is unable to synthesize any of the above compounds.AlaRS synthesizes Ap₄U very poorly, and Ap₄C and Ap₄G almost as effectively as Ap₄A. HisRS and TrpRS synthesize Ap₄G, Ap₄U and Ap₃U quite effectively, and Ap₄C very poorly. The fact that hybrid bisnucleoside tetraphosphates can be made by the same enzymes, and at rates comparable to Ap₄A, suggests that these compounds may also occur in vivo.Abbreviations HPLC high pressure liquid chromatography - PEI polyethyleneimine - RS aminoacyl tRNA synthetase     

P42×P39蝴蝶兰F_1代性状分离研究

以蝴蝶兰P42为母本、P39为父本进行常规杂交,研究其F1代性状的分离情况。结果表明:F1代各性状介于双亲之间或高于或低于双亲,表现为中亲优势或正向超亲优势或负向优势;从频次分布图分析,F1代的优势性状表现在叶数、叶色、花朵数和花色上,其中,花色、花朵数和叶色的变异系数最大,依次为29.16%、28.74%、28.32%,是F1代选择优良单株的重要依据。     

肺炎支原体P1蛋白的研究进展

肺炎支原体(MP)是引起呼吸系统感染常见的病原微生物,P1蛋白是肺炎支原体上一种与黏附相关的跨膜蛋白,其黏附作用是引发炎症作用的重要原因.目前新发现的一种被称为孤立岛3的P1变异体引起了各学者的广泛关注.另外,还可以利用P1蛋白进行MP感染的实验室诊断.因此,探讨P1蛋白基因结构、致病机制和实验室诊断方法具有重要意义.     

FXR1P相互作用RNA的研究

目的:本研究利用酵母三杂交系统从人脑海马回cDNA文库中筛选FXR1P的靶RNA,以进一步阐明FXR1基因的功能。方法:将表达FXR1P全长的质粒pYESTrp3/FXR1转化酵母菌株L40ura3/pHybLex/Zeo-MS2,检测毒性和自激活性;应用酵母三杂交技术从人脑海马回pRH3′-cDNA文库中筛选FXR1P的相互作用RNA;分离初步筛选的结果,再次转化含有诱饵质粒的融合菌株L40ura3/pHybLex/Zeo-MS2/pYESTrp3/FXR1,重新验证阳性结果;最后对阳性结果的外源插入片段进行测序和生物信息学分析。结果:酵母三杂交的筛选得到了3个阳性结果,经过测序和同源性分析,其中一个阳性结果中的插入片段为K-ALPHA-1 mRNA的部分序列。结论:K-ALPHA-1 mRNA可能是一种新的FXR1P的靶RNA。